Oxford Nanopore narrows loss, says its tracking toward breakeven in 2027 07:35, 19 Aug 2026 · Updated 13:14, 19 Aug
Biotech OKYO Pharma enrolls first patients in Phase 3 neuropathic corneal pain trial 13:29, 6 Oct 2026
Biotech Health & Bio Today: Fusion Antibodies refreshes platform after margin turnaround, Molecule Group 17:03, 5 Oct 2026
Market reports Daily reports The Premarket Brief London LIVE Small Caps Today Sector reports Mining Today Oil & Gas Today Health & Bio Today Tech Today
Energy & Resources Topics Oil & Gas Mining & Metals Renewables Nuclear Top Stocks AAL Anglo American ANTO Antofagasta FRES Fresnillo EDV Endeavour Mining GGP Greatland Gold See all companies
Financials Topics Banks Insurance Asset Management Fintech & Payments REITs & Property Top Stocks BARC Barclays HSBA HSBC LLOY Lloyds NWG NatWest AV. Aviva PRU Prudential See all companies
Technology Topics Software & SaaS Semiconductors AI & Machine Learning Cybersecurity Top Stocks SGE Sage Group RPI Raspberry Pi KNOS Kainos SCT Softcat See all companies
Healthcare Topics Pharma Biotech Medtech Healthcare Services Top Stocks AZN AstraZeneca GSK GSK SN. Smith & Nephew HIK Hikma See all companies
Industrials Topics Aerospace & Defence Construction Engineering Transport & Logistics Top Stocks BA. BAE Systems RR. Rolls-Royce BAB Babcock QQ. QinetiQ CHG Chemring See all companies
Consumer Topics Retail Food & Beverage Travel & Leisure Media & Entertainment Top Stocks DGE Diageo ULVR Unilever TSCO Tesco NXT Next See all companies
